Apixaban: Effective in Acute VTE; Lower Risk of Major Bleeding

The novel anticoagulant can now be considered for both acute and extended treatment of VTE, with a lower risk of major bleeding than standard treatment with enoxaparin and warfarin.
Source: Consultant Live - Category: Primary Care Source Type: news